home / stock / rhhby / rhhby articles

RHHBY Articles, Roche Holding Ltd ADR - From 10/19/23

Stock Information
Company Name: Roche Holding Ltd ADR
Stock Symbol: RHHBY
Market: OTC
Website: roche.com
Menu
RHHBY RHHBY Quote RHHBY Short RHHBY News RHHBY Articles RHHBY Message Board
Get RHHBY Alerts

News, Short Squeeze, Breakout and More Instantly...
Roche Reports Nine Months Sales Growth Despite Lower Sales From COVID-19 Products | Benzinga

Roche Holdings AG's (OTC: RHHBY) nine months sales increased by 1% (down 6% in CHF) to CHF 44.1 billion, even though the co...
What's Going On Cancer Player Monte Rosa Therapeutics Stock Today? | Benzinga

Monte Rosa Therapeutics Inc (NASDAQ: GLUE) entered into a strategic collaboration and licensing agreement with Roche Holdings AG (OT...

FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication | Benzinga

The FDA approved Merck & Co Inc's (NYSE: MRK) Keytruda for resectable (tumors ≥4 centimeters [cm] or node-positive) non-small ...

Why Is Alzheimer's Player Prothena Stock Trading Higher Today? | Benzinga

Prothena Corporation plc (NASDAQ: PRTA) is reportedly talking to advisors, potentially preparing for a sale. The closely watched Alzheimer'...
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready | Benzinga

Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic too...

Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges | Benzinga

Ionis Pharmaceuticals Inc (NASDAQ: IONS) entered an agreement with Roche Holdings AG (OTC: RHHBY) for two undisclosed early-sta...

Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year | Benzinga

In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVI...
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope | Benzinga

Alnylam Pharmaceuticals Inc's (NASDAQ: ALNY) KARDIA-1 Phase 2 study of zilebesiran, an investigational RNAi therapeutic targeting liver-ex...

Roche's Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer | Benzinga

Roche Holdings AG (OTC: RHHBY) announced that the Phase 3 ALINA study evaluating Alecensa (alectinib), compared with platinum-based chemothera...

Cancer Treatment In 7 Minutes: UK's Health Service To Rollout Roche's Tencentriq Injection Cutting Treatment Time | Benzinga

The U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval to the National Health Service (NHS) to im...
Previous 10 Next 10